Financials

Discussions Technicals Seasonals

6875 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to PHARMOSA BIOPHARM INC operating, investing, and financing activities

6875 free cash flow for Q4 24 is 14.58 M TWD. For 2024, 6875 free cash flow was -292.43 M TWD and operating cash flow was -127.16 M TWD.

Q3 '22

Q1 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

Q3 '22

Q1 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—